Tumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasis

Tumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasis

The lungs are ubiquitous receptacles of metastases originating from various bodily tumors. Although osteopontin (SPP1) has been associated with tumor dissemination, the role of its isoforms in lung-directed metastasis is incompletely understood. We employed syngeneic mouse models of spontaneous and...

Descripció completa

Dades bibliogràfiques
Autors principals:	Giopanou, I, Lilis, I, Papaleonidopoulos, V, Agalioti, T, Kanellakis, NI, Spiropoulou, N, Spella, M, Stathopoulos, GT
Format:	Journal article
Publicat:	Taylor and Francis 2016

Ítems similars

Tumor cell-derived osteopontin promotes lung metastasis via both cell-autonomous and paracrine pathways
per: Kanellakis, N, et al.
Publicat: (2016)

S8 Osteopontin as an airway epithelial tumour promoter
per: Psallidas, I, et al.
Publicat: (2016)

LSC Abstract – Osteopontin as an airway epithelial tumor promoter
per: Psallidas, I, et al.
Publicat: (2016)

Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion.
per: Antonia Marazioti, et al.
Publicat: (2013-01-01)

LSC Abstract – Host-environmental IL-1b drives mutant KRAS-IKKa addiction in malignant pleural effusion
per: Marazioti, A, et al.
Publicat: (2016)

Comprehensive Evaluation of Nuclear Factor-κΒ Expression Patterns in Non-Small Cell Lung Cancer.
per: Ioanna Giopanou, et al.
Publicat: (2015-01-01)

S7 Mouse lung adenocarcinoma cell lines reveal PRL2C2 as a novel lung tumour promoter
per: Kanellakis, N, et al.
Publicat: (2016)

Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight
per: Anne-Sophie Lamort, et al.
Publicat: (2019-08-01)

LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma
per: Giotopoulou, G, et al.
Publicat: (2017)

IκB Kinase α is required for development and progression of KRAS-mutant lung adenocarcinoma
per: Vreka, M, et al.
Publicat: (2018)

NRAS destines tumor cells to the lungs
per: Giannou, AD, et al.
Publicat: (2017)

Interleukin-1β provided by KIT-competent mast cells is required for KRAS-mutant lung adenocarcinoma
per: Ioannis Lilis, et al.
Publicat: (2019-07-01)

Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
per: Marazioti, A, et al.
Publicat: (2018)

Shared epithelial pathways to lung repair and disease
per: Magda Spella, et al.
Publicat: (2017-06-01)

Osteopontin and breast cancer metastasis: Possible role of genistein on the regulation of osteopontin
per: Kitboklang Khongsti, et al.
Publicat: (2021-11-01)

LSC-2017-Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
per: Kanellakis, N, et al.
Publicat: (2017)

Gene Expression Patterns of Osteopontin Isoforms and Integrins in Malignant Melanoma
per: Krisztina Jámbor, et al.
Publicat: (2022-08-01)

Expression pattern of osteopontin isoforms in malignant melanoma cell lines
per: Viktoria Koroknai, et al.
Publicat: (2024-01-01)

Two different isoforms of osteopontin modulate myelination and axonal integrity
per: Gisela Nilsson, et al.
Publicat: (2023-08-01)

cAMP-response element binding protein in KRAS-driven lung adenocarcinoma
per: Giotopoulou, G, et al.
Publicat: (2016)

RAS oncogenes direct metastasis
per: Magda Spella, et al.
Publicat: (2017-09-01)

The Trp53-Trp53inp1-Tnfrsf10b Pathway Regulates the Radiation Response of Mouse Spermatogonial Stem Cells
per: Kei Ishii, et al.
Publicat: (2014-10-01)

p53 regulation by TRP2 is not pervasive in melanoma.
per: Roland Houben, et al.
Publicat: (2014-01-01)

Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes.
per: Haley, V, et al.
Publicat: (2012)

Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
per: Antonia Marazioti, et al.
Publicat: (2018-02-01)

Distinct oncogenic phenotypes in hematopoietic specific deletions of Trp53
per: Jayanth Kumar Palanichamy, et al.
Publicat: (2023-05-01)

In vivo genome‐editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesis
per: Luuk Heitink, et al.
Publicat: (2022-03-01)

Functional characterization of stromal osteopontin in melanoma progression and metastasis.
per: Santosh Kumar, et al.
Publicat: (2013-01-01)

Osteopontin-enhanced hepatic metastasis of colorectal cancer cells.
per: Jianjin Huang, et al.
Publicat: (2012-01-01)

Na+/H+ exchanger isoform 1-induced osteopontin expression facilitates cardiomyocyte hypertrophy.
per: Iman A Mohamed, et al.
Publicat: (2015-01-01)

Chemosensitivity to doxorubicin in primary cells derived from tumor of FVB/N-Trp53tm1Hw1 with TALEN-mediated Trp53 mutant gene
per: Woobin Yun, et al.
Publicat: (2023-10-01)

NRAS destines tumor cells to the lungs
per: Anastasios D Giannou, et al.
Publicat: (2017-03-01)

Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes
per: Victoria L. Haley, et al.
Publicat: (2012-06-01)

Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in Trp53+/- mice
per: Blackburn AC, et al.
Publicat: (2012-04-01)

Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
per: Joachim Albers, et al.
Publicat: (2013-04-01)

Haploinsufficiency of Trp53 dramatically extends the lifespan of Sirt6-deficient mice
per: Shrestha Ghosh, et al.
Publicat: (2018-02-01)

RINT1 Loss Impairs Retinogenesis Through TRP53-Mediated Apoptosis
per: Anielle L. Gomes, et al.
Publicat: (2020-07-01)

Role of JNK in a Trp53-dependent mouse model of breast cancer.
per: Cristina Cellurale, et al.
Publicat: (2010-08-01)

Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases
per: Yun Zhang, et al.
Publicat: (2018-09-01)

Variable expressivity of the tumour suppressor protein TRP53 in cryopreserved human blastocysts
per: Stojanov Tomas, et al.
Publicat: (2007-10-01)